Forte Biosciences 15min chart shows Bollinger Bands Narrowing, Bearish Marubozu.

Forte Biosciences's 15-minute chart has exhibited a narrowing of Bollinger Bands and a bearish Marubozu pattern on August 13, 2023, at 09:45. This indicates a decrease in the magnitude of stock price fluctuations, suggesting that sellers are in control of the market and that bearish momentum is likely to persist.

Forte Biosciences Inc. (NASDAQ: FBRX) has experienced significant volatility following a 1-for-25 reverse stock split and a series of bearish technical indicators. On August 8, 2025, the company's stock fell 12.62% in pre-market trading, marking a notable decline in its stock performance. This drop occurred after the company implemented a reverse split, which aims to boost the stock price but can also lead to market volatility as the new share structure is adjusted [1].

The reverse split, effective August 8, 2025, reduced shareholder holdings by a factor of 25. This move is often undertaken to increase the stock price and attract more investors. However, the market's adjustment to the new share structure has led to increased volatility. Additionally, recent SEC filings reveal that Boothbay Fund Management, LLC and Ari Glass collectively own 0.8% of the shares, providing transparency into the company's shareholder structure [1].

Forte Biosciences' 15-minute chart has exhibited a significant bearish trend, as evidenced by a KDJ Death Cross and Bearish Marubozu pattern on August 7, 2025, at 13:00. This suggests a shift in momentum towards the downside, with potential for further depreciation in stock price [2]. The company's stock has seen a 17% pullback in the past week alone, adding to its one-year loss of 27% [2].

The reverse split and bearish technical indicators are not the only factors influencing Forte Biosciences' stock. The company's institutional ownership is relatively high, with over 50% of shares held by institutional investors. The largest shareholder, Federated Hermes, Inc., owns 8.8% of the company's shares, while Fred Alger Management, LLC holds 7.5% and Janus Henderson Group plc owns 5.7% [2]. This high level of institutional ownership could lead to significant sell-offs if the bearish trend persists.

Investors should monitor these developments closely and consider their broader market context before making investment decisions. The current market state, characterized by a paralysis awaiting key companies' quarterly results, may further exacerbate volatility [3].

References:
[1] https://www.ainvest.com/news/forte-biosciences-plunges-12-62-post-reverse-split-2508/
[2] https://www.ainvest.com/news/forte-biosciences-15-minute-chart-displays-kdj-death-cross-bearish-marubozu-2508/
[3] https://brameshtechanalysis.com/2025/07/16/nifty-in-the-eye-of-the-storm-a-market-paralyzed-before-the-weekend-juggernauts/